
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
L-type Ca++ CP γ1 CRISPR/Cas9 KO Plasmid (m) | sc-419413 | 20 µg | $397.00 |
Cacng1 encodes the L-type Ca++ channel γ1 auxiliary subunit, a tetraspan membrane protein that modulates biophysical properties and membrane expression of voltage-gated calcium channel complexes in excitable tissues. By tuning Ca++ influx, it influences excitation–contraction coupling, activity-dependent signaling, and downstream Ca++-regulated pathways that shape muscle physiology and cellular excitability. Altered regulation of L-type Ca++ channel components has been linked to perturbations in calcium homeostasis associated with neuromuscular and cardiac functional phenotypes, making Cacng1 a useful locus for dissecting channel auxiliary subunit biology in mouse models. Functional studies often interrogate how γ subunits affect channel gating, trafficking, and coupling to Ca++-dependent transcriptional responses.
L-type Ca++ CP γ1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Cacng1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Cacng1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Cacng1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish L-type Ca++ CP γ1 protein expression.
This CRISPR knockout system enables efficient generation of Cacng1-deficient cell models for investigation of L-type Ca++ CP γ1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.